There are 24 resources available
Update on the Clinical Efficacy of Targeted Agents: Indications, Efficacy and Toxicity
Presenter: B. Pistilli, FR
Session: Session 3 – Molecular Targets in TNBC Disease – TILs, PDL1 and Ki 67
Resources:
Slides
Webcast
Testing for the Target/Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation)
Presenter: G. Pruneri, IT
Session: Session 3 – Molecular Targets in TNBC Disease – TILs, PDL1 and Ki 67
Resources:
Slides
Webcast
A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board
Presenter: B. Pistilli, FR
Session: Session 3 – Molecular Targets in TNBC Disease – TILs, PDL1 and Ki 67
Resources:
Slides
Webcast
Biology and Testing of Biomarkers for Targeted Therapy in TNBC
Presenter: J. Balmaña, ES
Session: Session 4 – Molecular Targets in TNBC Disease – BRCA/PALB2 Germinal and Somatic Mutations
Resources:
Slides
Webcast
Update on the Clinical Efficacy of Targeted Agents: Indications, Efficacy and Toxicity
Presenter: C. Saura, ES
Session: Session 4 – Molecular Targets in TNBC Disease – BRCA/PALB2 Germinal and Somatic Mutations
Resources:
Slides
Webcast
A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board
Presenter: C. Saura, ES
Session: Session 4 – Molecular Targets in TNBC Disease – BRCA/PALB2 Germinal and Somatic Mutations
Resources:
Slides
Webcast
Value/Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for PDL1, BRCA, KI67 and TILs
Presenter: D. Trapani, IT
Session: Session 4 – Molecular Targets in TNBC Disease – BRCA/PALB2 Germinal and Somatic Mutations
Resources:
Slides
Webcast
Update on the Clinical Treatment Algorithm in HER2 Positive Disease (Early and Metastatic)
Presenter: J. Cortés, ES
Session: Session 5 – HER2 as a Target in Breast Cancer
Resources:
Slides
Webcast
HER2 Pathway: Testing HER2 Expression and HER2 Mutations
Presenter: A. Prat, ES
Session: Session 5 – HER2 as a Target in Breast Cancer
Resources:
Slides
Webcast
HER2 Low Disease – Clinical Trials and Challenges in Testing
Presenter: G. Curigliano, IT
Session: Session 5 – HER2 as a Target in Breast Cancer
Resources:
Slides
Webcast